advisors

Antonei B. Csoka, Ph.D.

We are delighted to introduce our scientific advisor, Dr. Antonei B. Csoka.

He has been actively involved in PSSD research and is currently conducting research on PSSD and PFS. With the help of Dr. Csoka's expertise, we aim to find new research opportunities, secure grant funding, and explore potential collaborations with other researchers.

BIOgraphy

Antonei B. Csoka, Ph.D. is an Associate Professor in the Department of Anatomy at Howard University, Washington DC, where he directs the Epigenetics Laboratory.

Dr. Csoka received his B.S. in Genetics from the University of Newcastle, his M.S. in Molecular Pathology from the University of Leicester, and his Ph.D. in Cell and Molecular Biology from the University of Debrecen. He performed postdoctoral research at the University of California, San Francisco, and Brown University.

He was a member of the consortium that identified the Lamin A gene as the cause of the accelerated aging disease, Hutchinson–Gilford Progeria Syndrome and participated in the first National Institutes of Health - Progeria Research Foundation workshop. He currently researches the molecular etiology of aging at the level of cellular senescence, gene expression and signaling pathways.

Dr. Csoka is an exponent of life-extension and cryonics, previously identified as one of the top twenty-three socially connected professors on Twitter. He is also a scientific advisor to the Alcor Life Extension Foundation, the UK Cryonics and Cryopreservation Research Network, and the Lifeboat Foundation, a fellow of the Global Healthspan Policy Institute, and was featured in the first Immortality Institute film, Exploring Life Extension (2005) produced by Bruce Klein.

Dr. Csoka has been researching Post-SSRI Sexual Dysfunction (PSSD) since 2004 and regards it as a syndrome best understood as an iatrogenic epigenetic disorder. He is applying whole-genome epigenetic and chromatin studies to investigate the effects of SSRIs both on human cells, and in animal models. He is also investigating analogous iatrogenic disorders such as Post-Finasteride Syndrome (PFS) and Fluoroquinolone-Associated Disability (FQAD), which may have overlapping etiologies.